Main Article Content

Authors

Introduction: Infection by Mycoplasma pneumoniae is becoming more frequent at younger ages. It appears as a generally benign and unspecific clinical condition of respiratory symptoms and sometimes responsible for a broad spectrum of extrapulmonary manifestations.
Objective: To describe demographic, clinical, laboratory, and treatment characteristics of pediatric-age patients with positive serology for M. pneumoniae diagnosed at the Pablo Tobón Uribe Hospital (HPTU) during the 2006-2008 period.
Materials and methods: Observational, retrospective study, which describes the demographic, clinical, laboratory, and treatment characteristics of patients from 1 month to 14 years of age with positive IgM for M. pneumoniae seen at HPTU during September 2006 and November 2008.
Results: We reviewed 305 clinical charts of patients with positive IgM for M. pneumoniae. The average age was 5.15 years ± 3.62 SD. Cough (87.5%), fever (65.9%), rhinorrea (39.3%), and respiratory difficulty (38%) were the most frequent clinical findings. Extrapulmonary compromise was mainly manifested in the skin (12.8%), the central nervous system (CNS) (3.6%), and osteomuscular system (3.9%). Auscultation and thoracic X-ray were normal in 33.1% and 30.8% of the patients, respectively. Episodes of asthma exacerbation were related to infection by Mycoplasma in 35% of the cases. A total of 51% of the patients required hospitalization with an average stay of seven days. All the patients received antibiotic treatment; clarithromycin (75.8%) was the antibiotic of choice.
Conclusion: Infection by M. pneumoniae has a broad range of clinical manifestations, requiring a high index of clinical suspicion and an active search for extrapulmonary compromise given that in our realm there is no specific diagnostic method for the acute infection.

Sánchez-Vargas FM, Gómez-Duarte OG. Mycoplasmapneumoniae - an emerging extra-pulmonary pathogen. ClinMicrobiol Infect. 2008; 14: 105-17.2.Alves-Vervloet L, Christophe M, Moreira-Camargos PA.Infection by Mycoplasma pneumoniae and its importance asan etiological agent in childhood community-acquiredpneumonias. Braz J Infect Dis. 2007; 11: 507-14.3.Gendrel D, Biscardi S, Marc E, Moulin F, Iniguez JL, RaymondJ. Mycoplasma pneumoniae, community-acquired pneumoniaand asthma. Arch Pediatr. 2005; 12 (Suppl 1): S7-11.4.Matas L, Molinos S, Fernández G, González V, Ausina N.Diagnóstico serológico de las infecciones por Mycoplasmapneumoniae. Enferm Infecc Microbiol Clin. 2006; 24: 19-23.5.Espinosa-Gimeno A, Martínez-Alfaro E, Meseguer-Ruiz V,Solera-Santos J. Infección por Mycoplasma y Chlamydia.Medicine. 1998; 7: 3687-92.6.American Academy of Pediatrics. Mycoplasma pneumoniaeinfections. In: Pickering LK (ed.) Red Book: Report of theCommittee on Infectious Diseases. 2 7th ed. Elk Grove Village:American Academy of Pediatrics;2006. p. 441-3.7.Ferwerda A, Moll HA, de Groot R. Respiratory tract infectionsby Mycoplasma pneumoniae in children: a review of diagnosticand therapeutic measures. Eur J Pediatr. 2001; 160: 483-91.8.Bébéar CM. Pathogenesis and laboratory diagnosis ofMycoplasma pneumoniae infections. Arch Pediatr. 2008; 15:1253-6.9. Paul MA, García C, Vega-Briceño L. Infección porMycoplasma pneumoniae. Rev Neumol Pediatr [on line] 2007[date of access 19 June 2009]; 2: 140-46. URL available in:http://www.neumologia-pediatrica.cl10. Bologna R. Mycoplasma pneumoniae: lo que nos queda porconocer. Arch Argent Pediatr. 2008; 106: 3-5.11. Paul MA, Vega-Briceño L, Potin M, Ferrés M, Pulgar D,García C, et al. Características clínicas de la enfermedad

Colombia Médica Vol. 42 Nº 2, 2011 (Abril-Junio)respiratoria causada por Mycoplasma pneumoniae en niñoshospitalizados. Rev Chilena Infectol. 2009; 26: 343-9.12. Grunfeld de Viú J, Scapin JP, Alarcón M. Infección respira-toria por Mycoplasma pneumoniae en pediatría. Arch ArgentPediatr. 2006; 104: 412-5.13. Waites KB, Talkington D. Mycoplasma pneumoniae and itsrole as a human pathogen. Clin Microbiol Rev. 2004; 17: 697-728.14. Higashigawa M, Kawasaki Y, Yodoya N, Omori Y, NashidaY, Amemiya Y, et al. Prevalence of Mycoplasma IgM inchildren with lower respiratory tract illness. Pediatr Int. 2009;51: 684-6.15. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G,Di Marco E, et al. Epidemiology and clinical features ofMycoplasma pneumoniae infection in children. Respir Med.2008; 102: 1762-8.16. Salas Mallea A. Infección por Mycoplasma pneumoniae enniños hospitalizados por neumonía. Rev Soc Bol Pediatr.2007; 46: 163-70.17. Hassan J, Irwin F, Dooley S, Connell J. Mycoplasmapneumoniae infection in a pediatric population: analysis ofsoluble immune markers as risk factors for asthma. HumImmunol. 2008; 69: 851-5.18. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinicalmanifestations, pathogenesis and laboratory detection ofMycoplasma pneumoniae infections. FEMS Microbiol Rev.2008; 32: 956-73.19. Garnier JM, Noël G, Retornaz K, Blanc P, Minodier P.Extrapulmonary infections due to Mycoplasma pneumoniae.Arch Pediatr. 2005; 12 (Suppl 1): S2-6.20. Othman N, Isaacs D, Daley AJ, Kesson AM. Mycoplasmapneumoniae infection in a clinical setting. Pediatr Int. 2008;50: 662-6.21. Dávila-Agüero G. Micoplasma en patología pulmonarpediátrica. Rev Peru Pediatr. 2007; 60: 101-4.22. Mc Cracken GH. Diagnosis and management of pneumonia inchildren. Pediatr Infect Dis J. 2000; 19: 924-8.23. Souliou E, Almasri M, Papa A, Theodoridou A. Diza E.Laboratory diagnosis of Mycoplasma pneumoniae respiratorytract infections in children. Eur J Clin Microbiol Infect Dis.2007; 26: 513-5.24. Loens K, Goossens H, Leven M. Acute respiratory infectiondue to Mycoplasma pneumoniae: current status of diagnosticmethod. Eur J Clin Microbiol Infect Dis. 2010; 29: 1055-69.25. Sánchez-Ruiz-Cabello J, Maldonado-Espinosa MJ, Rubio-Quevedo C, Rosales-Zabel JM, Pereira-Rodríguez MJ, Hol-gado-Carballo MA. Neumonía por Mycoplasma pneumoniaeen una zona básica de salud. An Esp Pediatr. 2001; 55: 108-12

Suárez, M. M., Elorza, M., Donado, J. H., Londoño, L. A., & Espinal, D. A. (2024). Clinical and epidemiological characteristics of pediatric patients with positive serology for Mycoplasma pneumoniae, treated in the third level hospital from 2006 to 2008. Colombia Medica, 42(2), 138–143. https://doi.org/10.25100/cm.v42i2.764 (Original work published June 14, 2011)

Downloads

Download data is not yet available.